GlassScriptPhysician profile
Drew Farmer
NPI 1124448972
$6,868.40
in general payments reported to CMS, 2019-2025
16 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $5,317 · 2023: $127 · 2024: $1,108 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $749 · Travel and Lodging: $698 · Education: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $749.14 |
| Travel and Lodging | $697.56 |
| Education | $104.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,277.83 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $787.41 | 2024 | Advantagerib, Ribfix Blu Advantage |
| Kls-Martin L.P. | $201.23 | 2022-2025 | |
| Integra Lifesciences Corporation | $174.71 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kerecis Limited | $154.91 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Abbvie INC. | $46.31 | 2023-2024 | |
| Kci USA, INC. | $30.91 | 2023 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Polynovo North America LLC | $26.76 | 2024 | Novosorb Btm |
| Ethicon US, LLC | $26.34 | 2024 | Stratafix |
| Atricure, INC. | $25.19 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $23.22 | 2023 | |
| Sanara Medtech INC. | $23.02 | 2022 | |
| Allergan, INC. | $21.91 | 2022 | |
| Teleflex LLC | $16.32 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $16.19 | 2024 | Exparel |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $16.14 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Drew Farmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.